Jesus Canales, PharmD
Current PGY1 Pharmacy Residents
Jesus Canales, PharmD: is currently a PGY-1 resident at Valley Baptist Brownsville. He graduated with his PharmD from Texas A&M Irma Lerma Rangel College of Pharmacy with honors. Dr. Canales is a member of the Rho Chi Pharmacy Honor Society and the American Society of Health-System Pharmacists (ASHP). Dr. Canales’ professional interests include critical care and infectious diseases. His current research projects focuses on the “Effects of protocol-guided versus non-protocol guided vasopressin utilization in septic shock” and the “Evaluation of Vasopressin Utilization in the Intensive Care Unit”. Upon completion of his PGY-1 pharmacy residency, Dr. Canales plans to pursue a PGY-2 in Critical Care and become board certified.
Jesus Canales, PharmD
Current PGY1 Pharmacy Residents
Jesus Canales, PharmD: is currently a PGY-1 resident at Valley Baptist Brownsville. He graduated with his PharmD from Texas A&M Irma Lerma Rangel College of Pharmacy with honors. Dr. Canales is a member of the Rho Chi Pharmacy Honor Society and the American Society of Health-System Pharmacists (ASHP). Dr. Canales’ professional interests include critical care and infectious diseases. His current research projects focuses on the “Effects of protocol-guided versus non-protocol guided vasopressin utilization in septic shock” and the “Evaluation of Vasopressin Utilization in the Intensive Care Unit”. Upon completion of his PGY-1 pharmacy residency, Dr. Canales plans to pursue a PGY-2 in Critical Care and become board certified.
Jesus Canales, PharmD
Current PGY1 Pharmacy Residents
Jesus Canales, PharmD: is currently a PGY-1 resident at Valley Baptist Brownsville. He graduated with his PharmD from Texas A&M Irma Lerma Rangel College of Pharmacy with honors. Dr. Canales is a member of the Rho Chi Pharmacy Honor Society and the American Society of Health-System Pharmacists (ASHP). Dr. Canales’ professional interests include critical care and infectious diseases. His current research projects focuses on the “Effects of protocol-guided versus non-protocol guided vasopressin utilization in septic shock” and the “Evaluation of Vasopressin Utilization in the Intensive Care Unit”. Upon completion of his PGY-1 pharmacy residency, Dr. Canales plans to pursue a PGY-2 in Critical Care and become board certified.